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Magnetic resonance imaging may be alternative to necropsy
Editor—Certification of the cause of death
is a valuable source of information about ill›
ness in the community. When a death is
unexplained the case is referred to the coro›
ner in England and Wales and the procura›
tor fiscal in Scotland. Although Scottish law
does not demand explanation of a non›
suspicious death, in England a cause of
death (or mode of death under certain
circumstances) must be determined, which
often requires a necropsy.
Necropsy is not allowed by many
religions, particularly Islam and Judaism,
unless demanded by law. Over the past 18
months we have used magnetic resonance
imaging to examine 15 patients whose
deaths were unexplained. The patients were
from areas in the North West region covered
by five coroners. Examination of the brain,
thorax, and upper abdomen showed that 10
of the patients had disease that was so severe
that, had the patients been alive, they would
have been at risk of death. In these cases the
coroners accepted the magnetic resonance
diagnoses as the cause of death. In the other
five cases disease was found but was not
deemed to be sufficiently severe to be the
definite cause of death. As there was
uncertainty about the cause a necropsy was
done. In four of the five cases necropsy con›
firmed that the disease shown by magnetic
resonance imaging was the cause of death.
Necropsy will always be the standard for
determining cause of death, particularly as
magnetic resonance imaging cannot show
small vessel coronary artery disease. How›
ever, for patients whose religious beliefs
make necropsy unwelcome magnetic reso›
nance imaging may offer a reasonable alter›
native. The cost and availability of magnetic
resonance imaging will prevent its wide›
spread use. There is also a good chance that
imaging will fail to show the cause of death
and a necropsy will be required. Despite
these drawbacks radiological investigations
may be as valuable in death as they are in
life.
Rob Bisset Consultant radiologist
X Ray Department, North Manchester General
Hospital, Manchester M8 6RB
Depression as a risk factor for
ischaemic heart disease in men
Two other community studies show
similar findings
Editor—Hippisley›Cox et al showed the
great potential of high quality general prac›
tice computer databases for use in epi›
demiological research in their elegant study
of depression as a risk factor for ischaemic
heart disease in men.1
It has long been recognised that psycho›
logical symptoms are associated with an
increased risk for physical disorders.2 The
intimate connections between the nervous,
endocrine, and immune systems provide a
mechanism through which psychological
changes can lead to changes in susceptibility
to physical illness.3 In my experience,
general practitioners are comfortable with
the concept that feelings and events in
people’s lives can predispose them to just
about any physical condition.
Hippisley›Cox et al suggest that research
in this area has been limited to studies of
small numbers of highly selected hospital
patients, but there have been at least two
long term community cohort studies. Bare›
foot and Schroll followed up a community
sample of 730 participants over 27 years
and showed that depression identified using
psychological tests in earlier life was
associated with a subsequent increase in
mortality from myocardial infarction, in
both men and women, over the whole range
of severity of depressive symptoms.4 Pratt et
al showed that dysphoria (two weeks of sad›
ness) at interview in 1981 was associated
with a twofold risk of myocardial infarction
at follow up in 1994, and this was not related
to the use of tricyclic antidepressants.5
Findings like these suggest that a history
of depression should heighten doctors’
suspicions when deciding whether or not to
investigate symptoms that may represent
ischaemic heart disease, regardless of
whether they believe the relation to be
causal. This is important since the tempta›
tion may be to ascribe a psychological origin
to physical symptoms in the presence of
depression.
Tony Kendrick Professor
Primary Medical Care, School of Medicine,
University of Southampton, Aldermoor Health
Centre, Southampton SO16 5ST
1 Hippisley›Cox J, Fielding K, Pringle M. Depression as a
risk factor for ischaemic heart disease in men: population
based case›control study. BMJ 1998;316:1714›9. (6 June.)
2 Eastwood MR, Trevelyan MH. Relationship between physi›
cal and psychiatric disorders. Psychol Med 1972;2:363›72.
3 Ader R, Cohen N, Felten D. Psychoneuroimmunology:
interactions between the nervous system and the immune
system. Lancet 1995;345:99›103.
4 Barefoot JC, Schroll M. Symptoms of depression, acute
myocardial infarction, and total mortality in a community
sample. Circulation 1996;93:1976›80.
5 Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ,
Eaten WW. Depression, psychotropic medication, and risk
of myocardial infarction—prospective data from the Balti›
more ECA follow›up. Circulation 1996;94:3123›9.
Key assumption about control group
undermines study’s validity
Editor—In their paper on the link between
depression and ischaemic heart disease
Hippisley›Cox et al made a key assumption
about their control group that undermines
the validity of their study.1 They assumed
that controls are as likely as cases to receive
a diagnosis of depression when one exists. I
suggest that the cases who had ischaemic
heart disease were much more likely to have
received a diagnosis of depression than were
the control group chosen.
The point prevalence for major depres›
sion in the general population is 5%.2 Many
depressed patients do not consult their doc›
tor, and about half of those who do will not
have their diagnosis recognised.3 A further
small proportion will have their depression
detected in subsequent consultations.
Patients with a recent diagnosis of ischaemic
heart disease are likely to see their general
practitioner on several occasions while diag›
nosis and treatment are secured. This means
that their doctor is much more likely to
detect their depressive illness than if they
consult infrequently or not at all.
The control group chosen by Hippisley›
Cox et al was not matched for the amount of
Advice to authors
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doctor›patient contact or for the presence of
a potentially life threatening condition.
Selecting a control group in this way is
highly likely to show higher rates of depres›
sion in the group with ischaemic heart
disease, and that is indeed what the study
found.
Geoff Earnshaw GP registrar
Town End Surgery, Caterham, Surrey CR3 5UJ
1 Hippisley›Cox J, Fielding K, Pringle M. Depression as a
risk factor for ischaemic heart disease in men: population
based case›control study. BMJ 1998;316:1714›9. (6 June.)
2 Paykel ES, Priest RG. Recognition and management of
depression in general practice: consensus statement. BMJ
1992;305:1198›202.
3 Goldberg D, Huxley P. Mental illness in the community. The
pathway to psychiatric care. London: Tavistock, 1980.
Authors’ reply
Editor—Kendrick has drawn our attention
to two cohort studies, both of which were
published after our initial literature search in
January 1996. Unfortunately we did not pick
them up at a later stage. None the less, we
are pleased to note that the findings broadly
concur with ours, adding to the evidence for
depression as a risk factor for ischaemic
heart disease.
In answer to Earnshaw’s first point, we
studied the depression before the date of
recorded diagnosis of ischaemic heart dis›
ease. As we described in the original paper,
when depression was first diagnosed in the
same year as the onset of ischaemic heart dis›
ease, it was assumed to have started after the
onset of ischaemic heart disease. We did this
to avoid possible confounding due to prodro›
mal depressive symptoms which can occur
immediately before myocardial infarction.
Earnshaw also criticises our choice of
control group, stating that it was not
matched for the presence of a potentially life
threatening condition. However, we did take
account of other major conditions—that is,
diabetes and hypertension—by adjusting for
them in the multivariate analysis.
Julia Hippisley›Cox Lecturer in general practice
Mike Pringle Professor of general practice
Division of General Practice, The Medical School,
Queen’s Medical Centre, Nottingham NG7 2UH
Effectiveness of treatments for
infantile colic
Dietary interventions in breast fed and
bottle fed infants should not be pooled
Editor—The pooled outcomes used in
Lucassen et al’s systematic review of
treatments for infantile colic are not
reported with their level of heterogeneity,
but the three trials dealing with soy formula
milk seem to be heterogeneous as the confi›
dence intervals do not overlap.1 It may
therefore be more useful to look at the
differences between the three trials rather
than pool the results. Excluding the trial of
lower methodological quality does not seem
to eliminate the heterogeneity.
The trial showing the large effect size
(that by Campbell2) is reported as having no
babies who were partially or totally breast
fed, while in the trial with the least effect
(that by Evans et al3) all babies were breast
fed. I wonder if this might explain the differ›
ence in outcomes.
The same reservation about pooling of
the results would apply to the two trials of
hypoallergenic formula milk. Although
there seems to be no statistical heterogen›
eity between them, in that by Hill et al two
thirds of the infants were breast fed4 and in
the other (by Forsyth) none were breast fed.5
Pooling results from diet trials with such
diverse levels of breast feeding may not
make clinical sense; surely results from
breast fed and bottle fed infants would be
better analysed separately.
Christopher Cates General practitioner
Manor View Practice, Bushey Health Centre,
Bushey, Hertfordshire WD2 2NL
1 Lucassen PLBJ, Assendelft WJJ, Gubbels JW, van Eijk JTM,
van Geldrop WJ, Knuistingh Neven A. Effectiveness of
treatments for infantile colic: systematic review. BMJ
1998;316:1563›9. (23 May.)
2 Campbell JPM. Dietary treatment of infantile colic: a
double›blind study. J R Coll Gen Pract 1989;39:11›4.
3 Evans RW, Fergusson DM, Allardyce RA, Taylor B.
Maternal diet and infantile colic in breast›fed infants.
Lancet 1981;i:1340›2.
4 Hill DJ, Hudson H, Sheffield LJ, Shelton MJ, Menhamen S,
Hosking CS. A low allergen diet is a significant
intervention in infantile colic: results of a community›
based study. J Allergy Clin Immunol 1995;94:886›92.
5 Forsyth BWC. Colic and the effect of changing formulas: a
double›blind, multiple›crossover study. J Pediatr 1989;
115:251›6.
Findings apply only to the most severely
affected infants
Editor—I am concerned that the literature
analysis by Lucassen et al may be used to
make recommendations for the care of any
infant reported to be colicky or to cry
persistently.1 Indeed, the advice to start a one
week trial of hypoallergenic formula is
potentially harmful as some mothers may
give up breast feeding—which is of proved
benefit—for an artificial feed of unproved
benefit. The authors have not made it
sufficiently clear that the findings of the
analysis apply only to the subgroup of
infants with the most severe colic (those who
meet a strict case definition and whose
carer(s) are willing to participate in a clinical
trial) and not to all infants who are reported
to cry excessively.
Case definitions are important determi›
nants of selection bias and hence generalis›
ability. One of the main sources of bias in
research into infantile colic has been the
lack of an objective and universally applied
case definition, and this has limited the pos›
sibilities for comparing the results of
different studies as well as the generalisabil›
ity of the results (table).2 Clever statistics are
not a solution for bias, which has to be
avoided through appropriate study design.
The selection bias of the studies included in
this analysis should be made explicit by
detailed description of the populations stud›
ied and the case definitions used; it is not
sufficient to state that trials were conducted
in general practice or community based
health services. In a large, unselected popu›
lation based study of infantile colic, rates of
infantile colic were higher in breast fed
babies than bottle fed babies.3 This argues
against cows’ milk protein causing a large
part of the burden of infantile colic in unse›
lected populations.
Infantile colic by any definition has no
adverse long term outcome for the infant.
Any problems stem from the carer’s frustra›
tion, sleeplessness, and distress. Never›
theless, because most researchers are
grounded in the medical model of disease
their approach has focused on finding a way
to “cure” the infant of this “disease.”
Natasha Crowcroft Senior registrar in public health
medicine
20 Beauval Road, London SE22 8UQ
1 Lucassen PLBJ, Assendelft WJJ, Gubbels JW, van Eijk JTM,
van Geldrop WJ, Knuistingh Neven A. Effectiveness of
treatments for infantile colic: systematic review. BMJ
1998;316:1563›9. (23 May.)
2 Crowcroft NS. Infantile colic. London: Faculty of Public
Health Medicine of the Royal College of Physicians, 1995.
[Dissertation submitted for part 2 of the examination for
membership of the faculty.]
3 Crowcroft NS, Strachan DP. The social origins of infantile
colic. BMJ 1997;314:1325›8.
Trial of hypoallergenic milk is not
supported by strong enough evidence
Editor—It is encouraging to see a subject
that troubles so many parents—infantile
colic—put through the rigours of a system›
atic review to find effective treatments.1 This
review could, however, be more explicit, as it
concentrates on colicky babies fed artificial
formula. In addition, the two trials of
hypoallergenic milks on which the conclu›
sions are based are small.
The study by Forsyth seems to have had
a drop out rate of 47%, with only 17 babies
accounted for.2 The babies, who were all
bottle fed, were given feeds over four day
periods alternating between a standard
formula and hypoallergenic milk, and the
mothers kept a diary of crying episodes
caused by colic. The abstract of this study
states that only in one baby was a clinically
Definitions of colic
Duration and timing:
>3 hours’ crying a day on >3 days a week in any 1 week
3 hours’ crying a day on 3 days a week for 3 weeks
Unexplainable periods of crying and restlessness, mostly
in the evenings
>2 hours’ excessive crying a day
>90 minutes’ excessive crying
>180 minutes’ distress in 24 hours when 24 hour
distress diary is used
Recurrent episodes of unexplained crying and irritability
that must have been present for at least 1 week in infants
aged <17 weeks
Evening colic; crying for >2 hours in the evening
3 hours’ crying a day for 1 week
Syndromes:
A behavioural syndrome characterised by excessive crying
that is paroxysmal in nature, more likely to occur in the
evenings, and without identifiable cause in an otherwise
healthy infant between 2 weeks and 4 months of age who
is difficult to console. Stiffening, drawing up of the legs
over the abdomen, and the passage of flatus are common
(although not invariable) accompaniments
Postprandial colic—three grades (not crying, occasional
crying or regular crying without pain, regular crying with
pain)
Diagnosis by parent or health visitor:
Parent or health visitor reports colic (yes/no)
Parent or health visitor reports colic on 5 point scale
Letters
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meaningful response reported with all three
formula changes. The article concluded that
the effect of hypoallergenic milk diminishes
with time and is only rarely reproducible.
Hill et al studied 38 bottle fed babies and 77
breast fed babies, whose mothers were
treated with a diet free of artificial colours
and preservatives; the breast feeding moth›
ers were also randomised to a treatment diet
that excluded milk, eggs, wheat, and nuts or
a control diet.3 The statistical results seem to
include both these groups of babies
together. Were they separated for this
systematic review?
I am concerned that the recommen›
dation of a one week trial of hypoallergenic
milk as a treatment for infantile colic for
babies receiving cows’ milk formula is not
supported by strong enough evidence.
Other recommendations listed are less
debatable—listening to and supporting par›
ents, offering reassurance, etc—although the
suggestion to avoid carrying and holding for
long periods seems contrary to instinct. A
discussion on treatments for breast fed
babies with colic would be useful.
Phyll Buchanan Supporter of breast feeding
Breastfeeding Network, PO Box 11126, Paisley
PA2 8YB
113327.1544@compuserve.com
1 Lucassen PLBJ, Assendelft WJJ, Gubbels JW, van Eijk JTM,
van Geldrop WJ, Knuistingh Neven A. Effectiveness of
treatments for infantile colic: systematic review. BMJ
1998;316:1563›9. (23 May.)
2 Forsyth BWC. Colic and the effect of changing formulas: a
double›blind, multiple›crossover study. J Pediatr 1989;
115:251›6.
3 Hill DJ, Hudson H, Sheffield LJ, Shelton MJ, Menhamen S,
Hosking CS. A low allergen diet is a significant
intervention in infantile colic: results of a community›
based study. J Allergy Clin Immunol 1995;94:886›92.
Authors’ reply
Editor—As Cates rightly assumes, the three
trials dealing with soy formula milk are
heterogeneous: a test of heterogeneity
yielded P < 0.05. One can try to explain
heterogeneity, ignore it (fixed effects model),
or model it (random effects model). We used
a random effects model in the pooling proc›
ess. Despite the statistical heterogeneity we
pooled the results of the individual trials; we
judged differences in the definition of colic,
outcome measures, and duration of inter›
vention to be small enough for pooling to be
allowed. This judgment is subjective, but
both breast fed and bottle fed colicky infants
experience the same (assumed) pathophysi›
ological process, the same intervention
(elimination of cows’ milk proteins), and the
same outcome (reduction of crying); the dif›
ferent reasons why parents decide to breast
feed or bottle feed are not important here.
We agree with Crowcroft’s remarks about
the one week trial of hypoallergenic formula
and the lack of uniform definitions of infan›
tile colic. Excessive crying, however, is the
most important characteristic in all defini›
tions. Additional symptoms are infrequently
assessed in studies on this subject. In our
systematic review we aimed to produce
results for very different interventions on a
common scale, thereby (subjectively) assum›
ing that in essence the same underlying
problem (excessive crying) was studied. The
definition of infantile colic assumes a
healthy, thriving infant. The assessment of
health is not, however, straightforward, as a
thriving infant with normal findings on
physical examination might, several days
later, be diagnosed as having cows’ milk
allergy or glenohumeral arthritis.1 There›
fore, instead of the words “infantile colic” we
prefer to redefine the problem according to
the definition of Carey2 and to distinguish
normal crying, secondary excessive crying
(for example, that caused by cows’ milk
allergy), and primary excessive crying. A one
week trial of a hypoallergenic formula
should be seen as a diagnostic test to rule
out cows’ milk allergy. In breast fed infants
the mother should eliminate cows’ milk pro›
teins from her diet. We did not mean to sug›
gest that breast feeding should be stopped.
We agree with Buchanan that the recom›
mendations on hypoallergenic formula are
based on small trials, but this is the best
available evidence. We did not present the
results for breast fed and bottle fed infants
separately as we assumed that the same
underlying mechanisms operated. The
advice for a one week trial of hypoallergenic
formula does not imply that breast feeding
should be stopped. We chose to compare the
number of clinically meaningful responses
to hypoallergenic formula and cows’ milk
formula in Forsyth’s study.3 If both treat›
ments are equally effective it is to be
expected that both kinds of treatment
changes cause an equal number of clinically
meaningful responses. We recognise, how›
ever, that more attention could have been
given to the lack of consistency in time.
P L B J Lucassen General practitioner
lucassen@knmg.nl
W J J Assendelft General practitioner
J T M van Eijk Professor of general practice
Institute for Research in Extramural Medicine, Free
University, Amsterdam, Netherlands
J W Gubbels Statistician
Organisation for Research and Policy Advice,
Grave, Netherlands
W J van Geldrop General practitioner
Scientific Committee of the Dutch College of
General Practitioners, Utrecht, Netherlands
A Knuistingh Neven General practitioner
Department of General Practice, University of
Leiden, Leiden, Netherlands
1 Lucassen PLBJ. Infantile colic in primary care. Occur›
rence, causes, treatments [dissertation]. Amsterdam: Free
University, 1998.
2 Carey WB. “Colic”—primary excessive crying as an infant›
environment interaction. Pediatr Clin North Am 1984;
31:993›1005.
3 Forsyth BWC. Colic and the effect of changing formulas: a





Results could be explained by
misinterpretation of macroscopic
appearances
Editor—I have serious doubts about the
validity of the data reported by Blanch et al
on embryonic abnormalities at medical
termination of pregnancy.1 In my experience,
embryos are delicate and can be readily
disrupted even during careful handling.
Although the authors state that “strict
criteria were used to distinguish structural
abnormalities from traumatic damage,” they
give no details of these criteria and whether
they have been generally accepted as
distinguishing between trauma and abnor›
mality in delicate embryonic tissue. I believe
that it is important to specify in how many
cases traumatic damage was seen.
Although Blanch et al state that macro›
scopically abnormal embryos were further
examined histologically, they do not report
the histological findings and I was surprised
that a pathologist was not included as an
author. Were all the neural tube and
abdominal wall defects confirmed histologi›
cally? It is easy to envisage how compression
of a delicate embryo during delivery might
induce rupture of both the abdomen and
central nervous system.
An anembryonic pregnancy rate of
23% (48 in 206 cases) before 9 weeks of
pregnancy is high in comparison with the
rate of 16% found in a study of 38 abnormal
early pregnancies2 and that of 1% in an
ultrasound study of 17 820 normal preg›
nancies (albeit 10›13 weeks’ gestation).3 Such
a discrepancy must be explained.
I believe that the unexpected finding of a
34% non›viable pregnancy rate can be
explained by misinterpretation of macro›
scopic appearances.
Michael Jarmulowicz Consultant histopathologist
Department of Histopathology, Royal Free Hospital
School of Medicine, Royal Free Hampstead NHS
Trust, London NW3 2QG
1 Blanch G, Quenby S, Ballantyne ES, Gosden CM, Neilson
JP, Holland K. Embryonic abnormalities at medical termi›
nation of pregnancy with mifepristone and misoprostol
during first trimester: observational study. BMJ 1998;
316:1712›3.
2 Alcazar JL, Laparte C, Lopez›Garcia G. Corpus luteum
blood flow in abnormal early pregnancy. J Ultrasound Med
1996;15:645›9.
3 Pandya PP, Snijders RJ, Psara N, Hilbert L, Nicolaides KH.
The prevalence of non›viable pregnancy at 10›13 weeks of
gestation. Ultrasound Obstet Gynecol 1996;7:170›3.
Authors’ reply
Editor—Most (80%) of the embryos that we
examined were delivered within intact
gestation sacs, protected from trauma by the
amniotic fluid and membranes, and without
any sign of tissue disruption macroscopi›
cally, microscopically, or histologically. In the
20% of pregnancies in which the gestation
sac had ruptured during abortion we used
strict histological criteria to distinguish
structural abnormalities from traumatic
damage. Three investigators studied each
embryo independently before a classifi›
cation was determined; when a neural
tube defect was suspected on macroscopic
inspection, the periderm (future dermis) was
examined meticulously and the embryo was
classed as having a neural tube defect only if
the skin surface was continuous with the
developing neural tissue; abdominal wall
defects were diagnosed only if there were
loops of bowel outside the abdominal wall
before Carnegie stage 16 or if other
Letters
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intra›abdominal organs such as the liver
were outside the abdominal wall and if the
edge of the periderm was histologically
rounded rather than ragged.
Anembryonic pregnancy was diagnosed
only when the gestation sac was intact. We
found an incidence of 33 out of 206 (16%).
This is identical with the rate of anembry›
onic pregnancy quoted by Alcazar et al.1 In
our study, the pregnancies were 6›9 weeks’
gestation. The discrepancy between the
anembryonic pregnancy rate in our study
and that in the study by Pandya et al (1%)2
can be explained by the fact that most
anembryonic pregnancies would have
ended in miscarriage by 10›13 weeks’ gesta›
tion in the other study.
We are confident that our methods did
not overestimate the incidence of pregnancy
abnormality.
Siobhan Quenby Lecturer
Geraldine Blanch Senior registrar
James Neilson Professor of obstetrics and gynaecology
Department of Obstetrics and Gynaecology,
University of Liverpool, Liverpool L69 3BX
1 Alcazar JL, Laparte C, Lopez›Garcia G. Corpus luteum
blood flow in abnormal early pregnancy. J Ultrasound Med
1996;15:645›9.
2 Pandya PP, Snijders RJ, Psara N, Hilbert L, Nicolaides KH.
The prevalence of non›viable pregnancy at 10›13 weeks of
gestation. Ultrasound Obstet Gynecol 1996;7:170›3.
Detection of changes in
mortality after heart surgery
Control limits failed to account for case
mix
Editor—We are concerned about the
graphical technique described by Poloniecki
et al in their analysis of perioperative
mortality rates associated with cardiac
surgery.1 Figure 2 shows three traces:
observed mortality performance bracketed
by control limits and plotted against the
number of successive cases performed. The
interpretation of the middle of the traces is
straightforward since it is simply a variable
life adjusted display that has previously been
described and will be familiar to many
cardiac surgeons in the United Kingdom.2
The use of control limits, on the other hand,
is new. However, the usefulness and indeed
the validity of these is not clear. As the
authors themselves note, their analysis does
not amount to a formal test of significance
since the control limits have not been
corrected for multiple testing; this is a major
deficiency. The use of 99% control limits
rather than 95% control limits presumably
increases their separation and makes them
more forgiving. It is not clear which level of
significance should be used, a difficulty com›
pounded by the fact that the limits are not
based on formal significance testing.
If we understand correctly, these control
limits have been calculated using a ÷2 distri›
bution. However, this fails to take into
account case mix and heterogeneity of risk,
the very things for which variable life
adjusted display plots are used. The follow›
ing example illustrates the danger in
ignoring case mix when estimating ranges of
variability. Consider operations on two
sequences of 1000 patients with different
underlying mortality risks that have been
assessed preoperatively (table). Based on the
given mortality risks, there is a 99%
probability that the number of deaths that
actually occur would fall in the range
shown in the last column. These ranges are
derived from exact calculations based on
the binomial expansion. Using a ÷2 distri›
bution would give a range (16 to 44) close
to the exact values obtained for the patients
in sequence 2, for whom no heterogeneity
of risk is present, but would substantially
overestimate the range for the patients
in sequence 1, for whom risks are
heterogeneous.
When examining surgical mortality, it is
important to take case mix into account.
However, this should be done not only when
estimating the expected mortality but also
when estimating the likely variability. Any
overestimation of likely ranges of variability
might well lead to undue complacency.
Steve Gallivan Director, Clinical Operational Research
Unit
Department of Mathematics, University College
London, London WC1E 6BT
Jocelyn Lovegrove Research fellow
Christopher Sherlaw›Johnson Senior research fellow
Clinical Operational Research Unit, University
College London
1 Poloniecki J, Valencia O, Littlejohns P. Cumulative risk
adjusted mortality chart for detecting changes in death
rate: observational study of heart surgery. BMJ
1998;316:1697›700. (6 June.)
2 Lovegrove J, Valencia O, Treasure T, Sherlaw›Johnson C,
Gallivan S. Monitoring the results of cardiac surgery by
variable life›adjusted display. Lancet 1997;350:1128›30.
Author’s reply
Editor—In order not to generate confusion
when referring to the cumulative risk
adjusted mortality chart, I suggest that Galli›
van et al stick to the original name for this
plotting technique, which I gave it in 1995.
Further details of the precedent are set out
at the end of our paper.
Unfortunately Gallivan et al are not
alone in the practice of claiming that a
surgeon is worse than his or her colleagues,
or that a colleague’s performance has
deteriorated (and then improved), without
any statistical basis for the assertion—that is,
without consideration of the rate of false
positives.1
The potential usefulness of control
limits is no doubt clear to Gallivan et al. In
their paper they state: “Some work on the
statistical approach to this question has been
done (Jan Poloniecki, unpublished observa›
tions).13” Their haste to submit the same data
with the same plotting technique to the
same journal at the same time may be
responsible for the fact that reference 13 has
been omitted from the list of references
published in the Lancet.1
Gallivan and his colleagues at University
College London are right in thinking that
nominal 99% control limits will give wider
confidence intervals, and therefore fewer false
positive results, than 95% limits based on the
same test. If, as we have suggested should
happen, a formal internal inquiry is launched
whenever the statistical control limits are
breached, then the confidence limits must be
wide enough to ensure that this does not
occur so often as to be unmanageable. For
our series, we found that the control limits for
the cumulative risk adjusted mortality were
breached at most twice in nearly four years.
The second occasion was particularly
transient—that is, self›correcting—and might
not have occurred at all if any of the para›
meters had been reset after the first occasion.
Gallivan et al suggest that the test could
be based on a multinomial distribution.
Both 0 and 100% are valid Parsonnet scores,
and with these risk estimates the multi›
nomial confidence limits have a width of 0.
None the less, they could try their sugges›
tion on, for example, the St George’s data,
which they have, to find out how often the
control limits for the cumulative risk
adjusted mortality chart are breached.
J D Poloniecki Lecturer in statistics
Department of Public Health Sciences, St George’s
Hospital Medical School, London SW17 0RE
1 Lovegrove J, Valencia O, Treasure T, Sherlaw›Johnson C,
Gallivan S. Monitoring the results of cardiac surgery by
variable life›adjusted display. Lancet 1997;350:1128›30.
Son’s reaction to his
circumcision was predictable
Editor—We should expect better from a
person with McFadyen’s training.1 Circumci›
sion is an unnecessarily radical, traumatic,
and invasive procedure for a simple problem.
Several researchers have found a more
conservative approach satis factory. All that is
necessary is to lyse the adhesions under some
type of anaesthesia, with application of
petroleum jelly to prevent readhesion during
the healing period.2 3
Even more troublesome is McFadyen’s
surprise at her son’s emotional reactions to
his penile surgery. The traumatic nature of
genital surgery has been known from the
time of Freud, who coined the term “castra›
tion anxiety.” There are ample reports in the
analytical literature of the traumatic effects
of circumcision.4 A thorough airing of the
trauma of circumcision has recently
appeared in a book.5 There should have
been no surprises.
George Hill Member, National Organization of
Circumcision Information Resource Centers of
Louisiana
Port Allen, Louisiana, USA
Gh44444@aol.com
Hypothetical operations on two groups of patients with different mortality risks
Case load Preoperative estimate of mortality risk (%)
Predicted
No of deaths
Exact 99% limits on
No of deaths
Sequence 1 (n=1000) 40 patients with 72%, 960 patients with 0.125% 30 22 to 38
Sequence 2 (n=1000) 1000 with 3% 30 17 to 45
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1 McFadyen A. Children have feelings too. BMJ
1998;316:1616›8. (23 May.)
2 Cooper GB, Thompson GJL, Raine PAM. Therapeutic
retraction of the foreskin in childhood. BMJ
1983;286:186›7.
3 MacKinlay GA. Save the prepuce. Painless separation of
preputial adhesions in the outpatient clinic. BMJ
1988;297:590›1.
4 Cansever G. Psychological effects of circumcision. Br J Med
Psychol 1965;38:321›31.
5 Goldman R. Circumcision: the hidden trauma. Boston:
Vanguard, 1997.
Professional and practice
development plans for primary
care teams
Academic GPs should not be ones to
decide whether service GPs are fit to
continue
Editor—Elwyn’s editorial about profes›
sional and practice development plans for
primary care is at best confused and at
worst dangerous.1 He comments that
there are good and bad practices and points
to the difference between the (apparently)
good and the (obviously) bad. The good
are paperless, with nurse practitioners,
physiotherapists, and on site phlebotomists;
the bad are those where consultations
are perfunctory, prescribing suspect, and
the sole aids are prescription pads, sick
notes, and unchecked sphygmomano›
meters.
What evidence does he have that being
paperless or having a nurse practitioner
leads to better patient care? My practice has
an on site physiotherapist, but this doesn’t
make us a better practice, just slightly
more convenient for patients. Neither
does our computer make us a better
practice. This false logic is part of an insidi›
ous trend: if you don’t have all the above
trappings plus a nurse facilitator doing your
audit and a business plan then you’re no
good. I’m sure that patients don’t see it this
way. The truth is that however much
academic general practitioners try to tinker
with general practice, with their talk of prac›
tice development, the patients will still be
there with the same problems, and it is our
job to be available and accessible, to listen,
diagnose, treat, or refer and to give
appropriate support. Elwyn fails to mention
any of these things, which are more
important than the esoteric matters with
which he is preoccupied.
Why do we need practice reaccredita›
tion? We’ve all passed our exams after years
of hard work, and, except for a small
number of black sheep, we’re all doing our
best for our patients. Lawyers, accountants,
engineers, architects, dentists, and vets
aren’t flagellating themselves in this way.
Voluntary “personal learning plans” are OK
if you want them. I know that the meetings
that I choose to attend and for which I get
postgraduate education allowance are
helpful to me and my patients, but trying to
prove this for reaccreditation purposes
would be difficult and is unnecessary. Some
things just have to be taken on professional
trust. It’s the crafty link between personal
learning plans and reaccreditation that
general practitioners must be most wary of.
Full time service general practitioners (as
the academics call them) don’t need people
like Elwyn deciding annually whether
they are fit to continue practising. Elwyn’s
editorial is really about a small number of
general practitioners trying to assert con›
trol over the rest of us. General practitioners
will let this happen at their peril.
John Eggleton Principal in general practice
Delph House Surgery, Exeter EX4 7HL
1 Elwyn GJ. Professional and practice development plans for
primary care teams. BMJ 1998;316:1619›20. (30 May.)
Network of GP tutors is well placed to
facilitate change
Editor—The chief medical officer’s review
of continuing professional development in
general practice1 has been long awaited by
educationists. As Elwyn points out, it will add
impetus to the move towards a “corporate”
rather than “independent practitioner”
vision of primary care.2 It should, however,
be introduced with care. General practition›
ers must be informed fully about the
proposed changes, which should be intro›
duced with the support of the networks of
general practice tutors. Many general practi›
tioners continue to feel aggrieved at the
imposition of the current postgraduate edu›
cation allowance system.
I have presented the findings of the
review at several meetings, and they have
been received with disdain by many general
practitioners. These general practitioners
mainly agree that the organisation of the
continuing professional development of
their primary healthcare teams is in disarray,
but they are reluctant to cooperate with any
change to the present system while what
they believe is their income (the postgradu›
ate education allowance) is threatened. I
agree with Elwyn that the change would be
more readily accepted if the allowance was
preserved as net income.
My main concern relates to the sugges›
tion that the acceptance of a practice profes›
sional development plan by the health
authority triggers payment of the post›
graduate education allowance. The post›
graduate general practice education organi›
sations must be responsible for
accreditation, as they have built up valuable
expertise since the introduction of the
allowance. The network of general practice
tutors is in an ideal position to facilitate the
change and support the general practition›
ers in completing their annual practice
professional development plans.
At the West Midlands Postgraduate
General Practice Education Unit we have
adapted our postgraduate education allow›
ance accreditation system to promote
individual learning plans and personal
learning. We have also developed an
ambitious mentoring scheme and have pro›
vided funds to enable some practices to
develop their own learning plans by
supporting educational activities.
My own practice is piloting a practice
professional development plan. The health
authority has ring fenced the staff and nurse
training budgets as a first step, and its
training adviser is on the steering com›
mittee. The plan has been formulated
by a multidisciplinary group, but we also
respect the needs of individuals and their
professional groupings. The general practi›
tioners are now satisfied that they will not
lose income to support the other staff, and
the plan is moving ahead. The plan
incorporates the practice’s audit and
research activity and reflects the agreed
quality issues and performance indicators.
We aim to publish a report at the end of the
first year.
Steve Field Director of postgraduate general practice
education,West Midlands
Postgraduate General Practice Education Unit,
Birmingham B15 3DP
s.field@bham.ac.uk
1 Department of Health. A review of continuing professional
development in practice: a report by the chief medical officer.Lon›
don: Department of Health, 1998.
2 Elwyn GJ. Professional and practice development plans for
primary care teams. BMJ 1998;316:1619›20. (30 May.)
Scheme with little funding and no
protected time will be forced on GPs
Editor—As a general practitioner who
enjoys his work and takes pride in his
specialty I had to ask myself why my heart
sank as I read the editorial by Elwyn.1 Am I
more cynical than I think? Do I deny the
need for me and my colleagues in our
primary care team to learn and develop
professionally? No. I realised that the
answer lay outside the team. I know that the
reality will be a scheme with little or no
funding and no protected time, forced on us
against a background of ever increasing
demand and continuing failure to develop
the team to carry out its existing workload,
let alone a new task. Of course the great and
the good will tell us that it is essential for us
to grasp this nettle, while the academic
departments will bombard us with glossy
brochures offering to provide a tailored
service at reasonable rates. The general
practitioners will cobble something to›
gether, miss another few lunches, and pick
up the tab.
Nothing new there, then.
Martin McCloskey General practitioner
Aberfoyle Medical Practice, Derry BT48 7PB
1 Elwyn GJ. Professional and practice development plans for
primary care teams. BMJ 1998;316:1619›20. (30 May.)
Didactic teaching by specialists can be
stimulating and effective
Editor—In his editorial about professional
and practice development plans for primary
care teams Elwyn makes two astounding
assertions.1 The notion that didactic teach›
ing is effectively dead surely requires a chal›
lenge. There may be occasions when
learning with other members of our practice
team is both relevant and helpful, but for
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most of the time I, and I suspect many other
general practitioners, have found regular
updates from acknowledged specialists to be
both stimulating and effective in the battle to
keep abreast of various subjects. The idea
that this established and popular method of
teaching could now be replaced by activities
that will doubtless include role play, group
work, and plenary sessions fills me with
gloom. For too long whole sections of
the medical establishment have blindly
endorsed such a teaching system without
ever trying to understand the antipathy and
even hostility that it generates.
The chief medical officer is, apparently,
promoting the “corporate” rather than the
“independent practitioner” vision of general
practice. Presumably this idea comes from
people living in the same ivory tower as
those whose understanding of the nuances
of general practice was so admirably shown
in the pill scare of two years ago. I have diffi›
culty squaring this corporate ideal with what
I still think is a most appropriate definition
of general practice and one that encapsu›
lates much of our work even though it was
written 35 years ago: “The family doctor
must interpret the patient, his problem and
circumstances to the consultant, explain the
need for hospital service and its possibilities
to the patient and ensure the necessary
communication with all concerned includ›
ing the relatives.”2
General practice must wake up. The so
called jewel in the crown of the NHS is
under threat of being dismantled; perhaps
we have already reached the stage of no
return when the author of this editorial is
able to write a sentence such as “Effective
strategies also use contextual and motiva›
tional influences.”
Frank Akerman General practitioner
Alma Road Surgery, Romsey, Hampshire
SO51 8ED
almaroad@enterprise.net
1 Elwyn GJ. Professional and practice development plans for
primary care teams. BMJ 1998;316:1619›20. (30 May.)
2 The field work of the family doctor. London: HMSO, 1963.
(Gillies report.)
PGEA system has resulted in great
achievements in general practice
education
Editor—Elwyn’s editorial on the chief
medical officer’s paper on continuing
professional development in general prac›
tice falls into the trap of taking the populist
view of the postgraduate education allow›
ance as being a didactic, ineffective, and top›
down system of education that has benefited
no one other than the pharmaceutical
industry.1 It also ignores the important fact
that the proposed professional›practice
education plan merely builds on the ideas of
self directed learning in general practice
education that were introduced through the
postgraduate education allowance as long
ago as 1991.2
The postgraduate education allowance
system has its flaws, and now is probably
the right time to move on; but it would be
wrong to ignore the remarkable achieve›
ments of general practice education since
its introduction. For the first time general
practitioners were treated as adult learners
given responsibility for their own personal
and professional development. They could
choose from a menu of educational oppor›
tunities that reflected their educational
needs and their preferred learning style.
There is nothing inherently wrong with
didactic teaching as long as it is appropriate
to the subject and is not the only form of
teaching. Although a few doctors may
have attended a meeting just to get the
postgraduate education allowance points,
most took advantage of distance learning
programmes, modular degree courses,
practice based educational activities (often
multiprofessional), and exciting personal
education plans (in Yorkshire alone we have
had some 200 completed personal/practice
education plans over the past seven years).
We have also developed reasonable exper›
tise in standard setting and monitoring of
accredited education. This will probably be
enormously important to the future of
reaccreditation and recertification in general
practice. And all that has been achieved at
little extra cost to taxpayers.
I hope that “life after the postgraduate
education allowance” will not be about
reinventing the wheel but about learning
from our experience and building on
what we have learnt. Please do not throw
the baby out with the bath water. Especially
if the water is clean and the baby happy.
Jamie Bahrami Director of postgraduate general
practice education
Department for NHS Postgraduate Medical and
Dental Education (Yorkshire), University of Leeds,
Leeds LS2 9JT
1 Elwyn GJ. Professional and practice development plans for
primary care teams. BMJ 1998;316:1619›20. (30 May.)
2 Bahrami J, Rogers M, Singleton C. Personal education
plan: a system of continuing medical education for general
practitioners. Educ Gen Pract 1995;4:342›5.
Reducing radon levels
Responsibility should be with local
authority
Editor—We now have direct evidence that
residential exposure to radon in the United
Kingdom causes lung cancer.1 This removes
one large hurdle on the route to effective
preventive action.
Radon remediation is based on good
epidemiology, is cost effective, and, because
the problem is small, is affordable. The
target population (houses) is well defined
and immobile. It does not suffer the
pragmatic obstacles of smoking or water
fluoridation—no civil liberties issue is at
stake, the remedy is not addictive, nobody is
advertising the remedy. But it lacks strong
advocacy and coordination of the efforts of
society, and remediation has been delayed
and incomplete.2 3 Because of high costs to
individual householders the results of tests
are confidential, and monitoring remedial
action is difficult.
Achieving change will mean using the
new study that Wise reports to influence
decision making at the level at which it is
being taken.1 Currently this is divided
between residents, landlords, local authori›
ties, health authorities, and the government.
Residents and landlords have to make an
immediate investment for a long term
benefit against competing priorities4 and
face a moral hazard that delaying action may
be rewarded by more central subsidy or
lower costs.
The benefits in the built environment
accrue more to society than to the current
occupier, and the operation of the free mar›
ket is likely to accentuate health inequalities.
Further exhortation of individuals, without
mandatory help,2 is the public health option
least likely to work. The National Radiologi›
cal Protection Board has provided good
information for 10 years, but remedial
action has not always followed.
Responsibility should be placed clearly
at a single level (probably the local authority,
though Our Healthier Nation suggests the
health authority5) and central government
should recognise the unequal financial
burden that the distribution of radon in
dwellings imposes on these authorities.
Michael Peter Le Geyt Senior house officer in
accident and emergency
Milton Keynes General Hospital, Milton Keynes
MK6 5LD
1 Wise J. Radon may account for one in 20 cases of lung
cancer. BMJ 1998;316:1557. (23 May.)
2 Jukes G. Action needed to prevent deaths from radon.
Environ Radon Newsletter 1996;8:3.
3 Taylor M. The new affected areas. Environ Radon Newsletter
1996;8:3.
4 Webb J. Radon in council houses: a shrinking problem.
Environ Radon Newsletter 1995;3:4.
5 Department of Health. Our healthier nation: a contract for
health. London: Stationery Office, 1998.
Householders are not prepared to pay
Editor—Wise talks about the recent report
on the risks of radon,1 and we were
interested to see the electronic response to
her article by Le Geyt.2 In Northampton›
shire, one of the areas affected by radon, we
have estimated the cost effectiveness of
radon remediation programmes. We have
shown that programmes in the NHS
workplace and domestic properties in
Northamptonshire are more cost effective
than the National Radiological Protection
Board’s recent proposals to reduce patient
doses in dental radiology.3 4 These are the
first reports of the cost effectiveness of actual
radon remediation programmes and are
similar to theoretical estimates.
It is four times more cost effective to
remediate houses than the workplace if
every house is remediated. In reality only
around 35% of houses have been tested in
Northamptonshire, and only a tenth of
householders finding raised radon levels
organise remedial work. Because of this the
cost effectiveness for houses is greatly
reduced and similar to that in the NHS
workplace.
Most houses in Northamptonshire were
tested during government sponsored free
testing, but remediation costs fall to the
householder. Thus the government is
getting poor value for money even if the
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programme can still be justified at a 10%
take up. Our work showed that a consider›
able proportion of householders whose
homes have radon levels just above the
action level decide not to proceed to
remediation, presumably because they think
that the moderate risk does not justify the
expense. We have also spoken to several
retired house owners, who argue that it is
not worth remediating their homes. We have
found that staff expect raised radon levels in
the workplace to be remediated immediately
but are reluctant to spend money to investi›
gate and remediate their own home, even
though they could be at greater risk in the
home.
In Northamptonshire we expect that
more houses will be remediated now that
surveyors ask about radon testing at the time
of a sale. Sweden, where there is a legal
requirement for householders to reduce
radon levels, has achieved 40% remediation.
Despite local publicity, builders of new
houses in Northamptonshire, who now
install radon›proof membranes under the
building regulations, prefer not to mention
the radon risk to purchasers from outside
Northamptonshire; they fail to advertise that
they comply with the required standards
and that purchasers are safe. How can we
encourage the public to take radon seri›
ously?
Antony Denman Head of medical physics
Northampton General Hospital, Northampton
NN1 5BD
Paul Phillips Senior lecturer
Nene University College, Northampton NN2 7AL
1 Wise J. Radon may account for one in 20 cases of lung
cancer. BMJ 1998;316:1557. (23 May.)
2 Le Geyt MP. Radon: case for a public health campaign.
www.bmj.com/cgi/eletters/316/7144/1553/I; EL1. (Pub›
lished above.)
3 Denman AR, Barker SP, Parkinson S, Phillips PS. The
health benefits and cost effectiveness of the radon mitiga›
tion programme in NHS properties in Northamptonshire.
J Radiol Prot 1997;17:253›9.
4 Denman AR, Phillips PS. A review of the cost effectiveness
of radon mitigation in domestic properties in Northamp›
tonshire. J Radiol Prot 1998;18:119›24.
Mentioning smoking as a cause
of death on death certificates
Relatives can be asked in death registries
about smoking habit of dead person
Editor—Robinson et al report that most
British doctors do not put smoking as a cause
of death.1 We should recognise, however, that
doctors will have difficulty in identifying a
clear link between smoking and death in indi›
vidual patients. The recommendation in the
report of the Scientific Committee on
Tobacco and Health that smoking status
should be “recorded as part of the death
registration process to aid monitoring the
evolving epidemic of tobacco related dis›
eases” is more practical.2 We agree that smok›
ing status should be recorded on all death
certificates and not only as a specified cause
of death, but further legislative changes to
introduce this will incur further delays. We
cannot expect more than one additional
question in the certificate, and this should ask
whether the dead person had been a regular
smoker. A smoking history should be
available in the medical record, but if it is
not then the doctor should ask the relatives.
Whether doctors are prepared to do this
reliably is questionable and needs further
study.
In a large case›control study in China
the smoking habits of people who had died
were obtained from their surviving
spouses in home interviews a few years after
the death,3 but this method is expensive. As
a quick alternative we are obtaining
information on the smoking habit of people
who have died by interviewing their
relatives at death registries. This has been
part of a case›control study throughout
1998.4 Relatives approaching a registration
counter are invited to complete a question›
naire about the person who has died and
about a control, who can be a surviving
spouse or another living relative. The pro›
cess takes only 10›15 minutes while the per›
son waits for the death certificate. All people
who have died at the age of >30 are
included.
Up to 5 October 1998 information on
smoking habit at about 10 years before
death was obtained from all death registries
in Hong Kong for 11 632 male and 9464
female people who had died. Ninety four
per cent of the relatives were willing to par›
ticipate. Altogether 8032 (69%) of the men
and 2052 of the women who had died had
smoked. Attributable risks due to smoking
can be calculated by comparing the smoking
status of the dead subjects with that of the
controls. We conclude that this method is
cheap, efficient, and acceptable to the
relatives and that it has potential for
immediate implementation in other coun›
tries, particularly those where death certifi›
cation is unreliable.
T H Lam Professor
S Y Ho Researcher
A J Hedley Professor
Department of Community Medicine, University of
Hong Kong, Hong Kong, China
hrmrlth@hkucc.hku.hk
K H Mak Consultant in community medicine
Department of Health, Wanchai, Hong Kong, China
1 Robinson L, Spencer J, Stacy R, Bhopal R. Smoking should
be mentioned as a cause of death on death certificates.BMJ
1998;316:1606. (23 May.)
2 Scientific Committee on Tobacco and Health (chairman D
Poswillo). Report. London: Department of Health, Depart›
ment of Health and Social Services, Northern Ireland,
Scottish Office Department of Health, Welsh Office, 1998.
3 Liu BQ, Peto R, Chen ZM, Boreham J, Campbell C, Chen
JS, et al. Nationwide case›control study of smoking and
deaths in China. In: Abstract book, 10th world conference on
tobacco or health, Beijing, 24›8 Aug 1997:27.
4 Ho SY, Lam TH, Hedley AJ, Mak KH. A pilot study on
mortality and smoking in Hong Kong. In: Abstract book,
10th world conference on tobacco or health, Beijing, 24›8 Aug
1997:113.
Relatives don’t like this being done
Editor—Robinson et al suggest that smok›
ing should be listed as a cause of death on
death certificates.1 In 1992, as a senior house
officer in respiratory medicine, I began to do
this. Within a few weeks it led to several
complaints from distressed relatives, who
inferred that doctors were apportioning
blame to the person who had died. In one
case I was even asked to reissue a certificate,
with smoking removed from the causes of
death. I have not since attempted to put
smoking on death certificates, and I suspect
that my experiences were not unique.
Paula Johnson Specialist registrar in respiratory
medicine
Pilgrim Hospital, Boston, Lincolnshire PE21 9QS
mmxphj@mmn1.medical.nottingham.ac.uk
1 Robinson L, Spencer J, Stacy R, Bhopal R. Smoking should
be mentioned as a cause of death on death certificates.BMJ
1998;316:1606. (23 May.)
Royal Medical Benevolent
Fund reminds readers of its
Christmas appeal
Editor—Christmas is one of the happiest
times for most of us. Those who this year
look forward to sharing the festivities within
a family circle have much to be grateful for.
Unfortunately, for some others this time of
year can, by contrast, bring sadness. Those
working on doctors’ behalf in the Royal
Medical Benevolent Fund know only too
well of the unexpected tragedies within our
profession and the resulting hardship—all
the more poignant when young children are
involved. The fund always seeks to give a
little extra help at Christmas time.
I have been president for less than a
year, but I am well aware of the fund’s
Christmas appeal. For the first time,
however, I now understand its success.
Thanks to doctors’ generosity it has done
well financially. Success, though, can be
measured in other ways—for example, by
perusal of some of the many charming
letters of thanks. These have given me a
clearer understanding of the great need and
why each year we must strive for still greater
success.
Contributions marked “Christmas
appeal” may be sent to the secretary of the
Royal Medical Benevolent Fund at the
address below or to the treasurer or medical
representative of readers’ local guild of the
fund.
Rodney Sweetnam President
Royal Medical Benevolent Fund, London
SW19 8QN
Correction
Odds ratios should be avoided when events are
common
Several errors occurred in this letter by Doug›
las G Altman et al (7 November, p 1318). The
last sentence should end “surely it makes sense
also to report the relative risk when this differs
markedly from the odds ratio” (not “surely it
makes no sense . . . .” as printed). Also, the first
name of the second author is Jonathan, not
Jonathon, and the second author of reference 2
is Bero LA, not Dero LA.
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